Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiographic Versus Pathology-Integrated Response for Assessing Optimal Surgical Timing After Neoadjuvant Imatinib in Patients With Locally Advanced KIT Exon 11-Mutant GIST.

Annals of surgery·2026
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.

European radiology experimental·2026
Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026
Same author

ASO Visual Abstract: Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis using Radiomics: An International Multi-center Cohort Study.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Mar 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

External validation of a multi-institutional retroperitoneal sarcoma nomogram.

Chandrajit P Raut1,2, Rosalba Miceli3, Dirk C Strauss4

  • 1Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Cancer
|February 27, 2016
PubMed
Summary

This study validated a nomogram for predicting survival in retroperitoneal sarcoma (RPS) patients. The nomogram accurately estimates disease-free and overall survival, offering a better alternative to current staging systems.

Keywords:
gradehistologymultifocalitynomogramretroperitoneal sarcomastagingsurgery

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

846
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

846
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Sarcoma Research

Background:

  • Primary retroperitoneal sarcoma (RPS) survival prediction is crucial.
  • Existing staging systems like the American Joint Committee on Cancer (AJCC) may not fully capture prognostic factors.
  • A nomogram incorporating additional prognostic factors has been developed.

Purpose of the Study:

  • To externally validate a multi-institutional nomogram for predicting disease-free survival (DFS) and overall survival (OS) in patients with primary RPS.
  • To assess the nomogram's generalizability and calibration in an independent cohort.

Main Methods:

  • A validation cohort of 631 RPS patients from 6 European and North American sarcoma centers was used.
  • The nomogram, based on 6 variables (age, tumor size, grade, histologic subtype, multifocality, surgery quality), was applied to the validation set.
  • Discriminative ability was assessed using Harrell C statistics, and predicted probabilities were compared to observed outcomes.

Main Results:

  • The validation cohort showed 7-year DFS of 38% and OS of 58%.
  • All 6 nomogram variables were independently prognostic.
  • The nomogram demonstrated good calibration with Harrell C statistics of 0.69 for DFS and 0.73 for OS in the validation set.

Conclusions:

  • The RPS nomogram was successfully externally validated in a large, independent cohort.
  • The nomogram is generalizable for patients treated at specialized sarcoma centers.
  • It offers a more individualized and accurate survival prediction for RPS compared to the AJCC staging system.